Lentivirus transduced interleukin‑1 receptor antagonist gene expression in murine bone marrow‑derived mesenchymal stem cells in vitro

He,Tao; Chi,Guanghao; Tian,Bo; Tang,Tingting; Dai,Kerong

doi:10.3892/mmr.2015.4003

Lentivirus transduced interleukin‑1 receptor antagonist gene expression in murine bone marrow‑derived mesenchymal stem cells in vitro

Authors:
- Tao He
- Guanghao Chi
- Bo Tian
- Tingting Tang
- Kerong Dai
View Affiliations

Affiliations: Department of Orthopedics, Shanghai Key Laboratory of Orthopedic Implants, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China
Published online on: June 26, 2015 https://doi.org/10.3892/mmr.2015.4003
Pages: 4063-4070
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Genetically modified mesenchymal stem cells have been used in attempts to increase the expression of interleukin‑1 receptor antagonist (IL‑1Ra); however, the attempts thus far have been unsuccessful. The aim of the present study was to investigate whether the lentivirus transduced IL‑1Ra gene was able to be stably expressed in murine bone marrow‑derived mesenchymal stem cells (mBMSCs) in vitro. In the present study, third generation lentiviral (Lv) vectors transducing the IL‑1Ra/green fluorescent protein (copGFP) gene were constructed and transfected into mBMSCs to establish the Lv.IL‑1Ra.copGFP/mBMSCs, which were evaluated using fluorescence microscopy, flow cytometry, cell viability analysis using a cell counting kit‑8 kit, Trypan blue staining and an MTT growth kinetics assay. The expression of IL‑1Ra was analyzed using reverse transcription-quantitative polymerase chain reaction and western blotting. The results demonstrated that the Lv.IL‑1Ra/copGFP vector was successfully constructed. The mBMSCs exhibited a short proliferation life, however they had good growth kinetics at an early stage and improved viability following efficient transduction of the IL‑1Ra gene. IL‑1Ra was overexpressed following transfection of mBMSCs. In conclusion, lentiviral vector transduced mBMSCs were able to efficiently express exogenous Il‑1Ra under certain conditions and had a marked capacity for proliferation.

View Figures

View References

1	Gala K, Burdzińska A, Idziak M, Makula J and Pączek L: Characterization of bone-marrow-derived rat mesenchymal stem cells depending on donor age. Cell Biol Int. 35:1055–1062. 2011. View Article : Google Scholar : PubMed/NCBI
2	McGinley L, McMahon J, Strappe P, Barry F, Murphy M, O'Toole D, et al: Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia. Stem Cell Res Ther. 2:122011. View Article : Google Scholar :
3	Dinarello CA: The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med. 343:732–734. 2000. View Article : Google Scholar : PubMed/NCBI
4	Arend WP, Malyak M, Guthridge CJ and Gabay C: Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 16:27–55. 1998. View Article : Google Scholar : PubMed/NCBI
5	Prockop DJ and Oh JY: Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 20:14–20. 2012. View Article : Google Scholar :
6	Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S and Lukic ML: Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity. 43:255–263. 2010. View Article : Google Scholar
7	Shi XL, Zhu W, Tan JJ, Xiao JQ, Zhang L and Xu Q: Effect evaluation of interleukin-1 receptor antagonist nanopar-ticles for mesenchymal stem cell transplantation. World J Gastroenterol. 19:1984–1991. 2013. View Article : Google Scholar : PubMed/NCBI
8	Doughty LA, Patrene KD, Evans CH, Boggs SS and Robbins PD: Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10. Gene Ther. 4:252–257. 1997. View Article : Google Scholar : PubMed/NCBI
9	Boggs SS, Patrene KD, Mueller GM, Evans CH, Doughty LA, et al: Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA. Gene Ther. 2:632–638. 1995.PubMed/NCBI
10	Zhang X, Zhang C, Tang T, Qu Z, Lou J and Dai K: Immunomodulatory and osteogenic differentiation effects of mesenchymal stem cells by adenovirus-mediated coexpression of CTLA4Ig and BMP2. J Orthop Res. 26:314–321. 2008. View Article : Google Scholar
11	Amendola M, Venneri MA, Biffi A, Vigna E and Naldini L: Coordinate dual gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol. 23:108–116. 2005. View Article : Google Scholar
12	Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
13	Laitala-Leinonen T: Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systems. J Negat Results Biomed. 4:5–13. 2005. View Article : Google Scholar : PubMed/NCBI
14	Beyth S, Schroeder J and Liebergall M: Stem cells in bone diseases: current clinical practice. Br Med Bull. 99:199–210. 2011. View Article : Google Scholar : PubMed/NCBI
15	Devine MJ, Mierisch CM, Jang E, Anderson PC and Balian G: Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res. 20:1232–1239. 2002. View Article : Google Scholar : PubMed/NCBI
16	Wang L, Li Y, Chen J, Gautam SC, Zhang Z, Lu M, et al: Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol. 30:831–836. 2002. View Article : Google Scholar : PubMed/NCBI
17	Xiang J, Tang J, Song C, Yang Z, Hirst DG, Zheng QJ, et al: Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy. 11:516–526. 2009. View Article : Google Scholar : PubMed/NCBI
18	Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V and Lavroukov A: Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med. 344:385–386. 2001. View Article : Google Scholar : PubMed/NCBI
19	Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD and McNall RY: Isolated allogeneic bone marrow-derived mesen-chymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 99:8932–8937. 2002. View Article : Google Scholar
20	Chen SL, Fang WW, Ye F, Liu YH, Qian J and Shan SJ: Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 94:92–95. 2004. View Article : Google Scholar : PubMed/NCBI
21	Oh JY, Roddy GW, Choi H, Lee RH, Ylöstalo JH, Rosa RH, et al: Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA. 107:16875–16880. 2010. View Article : Google Scholar : PubMed/NCBI
22	Choi H, Lee RH, Bazhanov N, Oh JY and Prockop DJ: Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood. 118:330–338. 2011. View Article : Google Scholar : PubMed/NCBI
23	Guo Z, Li H, Li X, Yu X, Wang H, Tang P, et al: In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells. 24:992–1000. 2006. View Article : Google Scholar : PubMed/NCBI
24	Xu S, De Becker A, Van Camp B, Vanderkerken K and Van Riet I: An improved harvest and in vitro expansion protocol for murine bone marrow-derived mesenchymal stem cells. J Biomed Biotechnol. 2010:1059402010. View Article : Google Scholar :
25	Cheng CC, Lian WS, Hsiao FS, Liu IH, Lin SP, Lee YH, et al: Isolation and characterization of novel murine epiphysis derived mesenchymal stem cells. PloS One. 7:e360852012. View Article : Google Scholar : PubMed/NCBI
26	Gao Z, Golob J, Tanavde VM, Civin CI, Hawley RG and Cheng L: High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells. 19:247–259. 2001. View Article : Google Scholar : PubMed/NCBI
27	Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF and Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation and differentiation potential. Blood. 103:1662–1668. 2004. View Article : Google Scholar
28	Guo Z, Li H, Li X, Yu X, Wang H, Tang P, et al: In vitro characteristics and in vivo immunosuppressive activity of compact bone-derived murine mesenchymal progenitor cells. Stem Cells. 24:992–1000. 2006. View Article : Google Scholar : PubMed/NCBI
29	Dinarello CA: Biologic basis for interleukin-1 in disease. Blood. 87:2095–2147. 1996.PubMed/NCBI
30	He T, Wu W, Huang Y, Zhang X, Tang T and Dai K: Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. Int Orthop. 37:1025–1031. 2013. View Article : Google Scholar : PubMed/NCBI
31	Campion GV, Lebsack ME, Lookabaugh J, Gordon G and Catalano M: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum. 39:1092–1101. 1996. View Article : Google Scholar : PubMed/NCBI
32	Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, et al: Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA. 104:11002–11007. 2007. View Article : Google Scholar : PubMed/NCBI
33	Wu H, Lu W and Mahato RI: Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation. Pharm Res. 28:2098–2109. 2011. View Article : Google Scholar : PubMed/NCBI
34	Löw K, Blesch A, Herrmann J and Tuszynski MH: A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury. Gene Ther. 17:577–591. 2010. View Article : Google Scholar : PubMed/NCBI
35	Zheng YB, Zhang XH and Huang ZL: Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS One. 7:e413922012. View Article : Google Scholar : PubMed/NCBI
36	Dozza B, Di Bella C, Lucarelli E, Giavaresi G, Fini M, Tazzari PL, et al: Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non-cemented hip prosthesis integration. J Orthop Res. 29:961–968. 2011. View Article : Google Scholar : PubMed/NCBI
37	Ramnaraine ML, Mathews WE and Clohisy DR: Lentivirus transduction of human osteoclast precursor cells and differentiation into functional osteoclasts. Bone. 50:97–103. 2012. View Article : Google Scholar